Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
83,364,887
-
Share change
-
+311,914
-
Total reported value
-
$469,356,678
-
Put/Call ratio
-
87%
-
Price per share
-
$5.63
-
Number of holders
-
122
-
Value change
-
+$1,703,918
-
Number of buys
-
3
-
Number of sells
-
4
Institutional Holders of OREXIGEN THERAPEUTICS INC - COM (OREX) as of Q4 2013
As of 31 Dec 2013,
OREXIGEN THERAPEUTICS INC - COM (OREX) was held by
122 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
83,364,887 shares.
The largest 10 holders included
Capital Research Global Investors, Partner Fund Management, L.P., FIRST MANHATTAN CO, State Street Corp, SAC Capital Advisors LP, BlackRock Fund Advisors, BANK OF AMERICA CORP /DE/, FMR LLC, BlackRock Institutional Trust Company, N.A., and VANGUARD GROUP INC.
This page lists
122
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.